PDGFRα in Liver Pathophysiology: Emerging Roles in Development, Regeneration, Fibrosis, and Cancer

被引:29
|
作者
Kikuchi, Alexander [1 ]
Monga, Satdarshan Pal [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol & Med, Pittsburgh, PA 15261 USA
来源
GENE EXPRESSION | 2015年 / 16卷 / 03期
关键词
Platelet-derived growth factor (PDGF); Liver development; Liver regeneration; Hepatic fibrosis; Cirrhosis; Hepatocellular carcinoma; Cholangiocarcinoma; beta-Catenin; NF-kappa B; Transforming growth factor-beta (TGF-beta); Oxidative stress; Sorafenib; IMC-3G3; APA5; GROWTH-FACTOR-RECEPTOR; HEPATIC STELLATE CELLS; HUMAN HEPATOCELLULAR CARCINOMAS; CONNECTIVE-TISSUE CELLS; THERAPEUTIC TARGET; TGF-BETA; ENDOTHELIAL-CELLS; RELEVANT BIOMARKERS; DIFFERENTIAL ROLES; OXIDATIVE STRESS;
D O I
10.3727/105221615X14181438356210
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Platelet-derived growth factor receptor alpha (PDGFR alpha) is an isoform of the PDGFR family of tyrosine kinase receptors involved in cell proliferation, survival, differentiation, and growth. In this review, we highlight the role of PDGFR alpha and the current evidence of its expression and activities in liver development, regeneration, and pathology-including fibrosis, cirrhosis, and liver cancer. Studies elucidating PDGFR alpha signaling in processes ranging from profibrotic signaling, angiogenesis, and oxidative stress to epithelial-to-mesenchymal transition point toward PDGFR alpha as a potential therapeutic target in various hepatic pathologies, including hepatic fibrosis and liver cancer. Furthermore, PDGFR alpha localization and modulation during liver development and regeneration may lend insight into its potential roles in various pathologic states. We will also briefly discuss some of the current targeted treatments for PDGFR alpha, including multireceptor tyrosine kinase inhibitors and PDGFR alpha-specific inhibitors.
引用
收藏
页码:109 / 127
页数:19
相关论文
共 50 条
  • [21] Angiogenesis in liver regeneration and fibrosis: "a double-edged sword"
    Kaur, Savneet
    Anita, K.
    HEPATOLOGY INTERNATIONAL, 2013, 7 (04) : 959 - 968
  • [22] Complement and the central nervous system: emerging roles in development, protection and regeneration
    Rutkowski, Martin J.
    Sughrue, Michael E.
    Kane, Ari J.
    Mills, Steven A.
    Fang, Shanna
    Parsa, Andrew T.
    IMMUNOLOGY AND CELL BIOLOGY, 2010, 88 (08) : 781 - 786
  • [23] Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches
    Rajapaksha, Indu
    LIVERS, 2022, 2 (04): : 372 - 386
  • [24] Type 3 cytokines in liver fibrosis and liver cancer
    Molina, Manuel Flores
    Abdelnabi, Mohamed N.
    Fabre, Thomas
    Shoukry, Naglaa H.
    CYTOKINE, 2019, 124
  • [25] Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
    Parola, Maurizio
    Pinzani, Massimo
    MOLECULAR ASPECTS OF MEDICINE, 2024, 95
  • [26] Adverse outcome pathway development from protein alkylation to liver fibrosis
    Horvat, Tomislav
    Landesmann, Brigitte
    Lostia, Alfonso
    Vinken, Mathieu
    Munn, Sharon
    Whelan, Maurice
    ARCHIVES OF TOXICOLOGY, 2017, 91 (04) : 1523 - 1543
  • [27] BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
    Herrera, Blanca
    Addante, Annalisa
    Sanchez, Aranzazu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [28] Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis
    Wang, Ji-nian
    Li, Li
    Li, Liang-yun
    Yan, Qi
    Li, Jun
    Xu, Tao
    GENE, 2018, 674 : 57 - 69
  • [29] Pathophysiology of Cystic Fibrosis Liver Disease
    Kasper, Vania L.
    Assis, David N.
    PEDIATRIC PULMONOLOGY, 2024, 59 : S98 - S106
  • [30] Wnt signaling in liver regeneration, disease, and cancer
    Zou, Gengyi
    Park, Jae-Il
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 33 - 50